Form 4 for BMY Bristol Myers Squibb
Accepted 2022-09-22 00:00:00 ET · period of report 2022-09-20 · accession 0000014272-22-000174 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-22 | 2022-09-20 | BMY | Caforio Giovanni | CEO, Board COB, Dir | S - Sale | $69.71 | -25.0K | 476.1K | -5% | -$1.74M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.10 par value | 2022-09-20 | S | D | 25,000 | $69.71 | 476,104.33 | D | — | — | (F1) The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 11, 2021. |